Assisting to Integrate Hepatitic C Services into Opioid Treatment Programs in the Midwest

University of Missouri–Kansas City

In July 2020, the Addiction Technology Training Center (ATTC) at the University of Missouri, Kansas City released a toolkit entitled Your Guide to Integrating HCV Services into Opioid Treatment Programs, Promising and Emerging Best Practices. Though methadone programs can be ideal places to provide hepatitis C treatment — since many people with hepatitis C already go there every day — policy barriers separate drug treatment and primary care, often making it challenging to provide non-methadone medications in methadone programs.

Facente Consulting worked with the ATTC to supplement their toolkit by writing up case studies of three methadone programs that had successfully incorporated HCV services into their model and completing white papers on several topics, including COVID vulnerability for people who use drugs and updated data trends on HIV, HCV, and overdose.